Actively Recruiting
Multimodal VR Rehabilitation for Cardiorespiratory Fitness in CABG Phase II
Led by Riphah International University · Updated on 2026-01-12
66
Participants Needed
1
Research Sites
12 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
It will be a randomized clinical trial with a sample size of 66. A convenient sampling technique will be used to recruit the CABG phase II patients for the study. Then, they will be divided into three groups by block randomization. Weight-bearing Liuzijue Qigong will be given as a baseline treatment to all groups. In group A, patients will engage in multimodal circuit training while simultaneously viewing the nature scenes through VR in a clinical setting, in group B, patients will be given multimodal circuit training in a clinical setting while in group C, patients will be given multimodal circuit training through telerehabilitation. The dyspnea 12 Questionnaire will be used for measuring dyspnea, Cooper's 12-minute test will be used to assess cardiorespiratory fitness, echocardiography will be used to assess Left ventricular ejection fraction, EQ-5D-5L will be used to assess quality of life, and Pittsburgh Sleep Quality Index (PSQI) will be used to assess the quality of sleep. Data will be entered and analyzed through SPSS version 21.
CONDITIONS
Official Title
Multimodal VR Rehabilitation for Cardiorespiratory Fitness in CABG Phase II
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who underwent CABG surgery will be recruited after twelve weeks
- Both male and female
- Age 30-60 years old
- Left ventricular ejection fraction (LVEF) less than 40%
- Persistent dyspnea with a self-rated intensity of 5 or more on a visual analogue dyspnea scale
- Preserved cognitive function (Montreal Cognitive Assessment score greater than 24)
You will not qualify if you...
- History of repeated CABG surgery
- Non-cardiac surgical procedure within 2 months prior to recruitment
- Unstable angina, uncontrolled hypertension (blood pressure over 180/100 mmHg), pacemaker or atrial fibrillation, valve stenosis, or symptomatic peripheral arterial disease limiting exercise
- Chronic obstructive pulmonary disease with FEV1 and FVC less than 60%
- Any shoulder injury limiting exercise participation
- Kinesiophobia
- Epilepsy, vertigo, or eyesight impairment contraindicating VR use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Riphah International University
Lahore, Punjab Province, Pakistan, 54000
Actively Recruiting
Research Team
W
Wajeeha Zia, PP-DPT
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here